logo
Plus   Neg
Share
Email

Sanofi Agrees To Buy Principia Biopharma In $3.68 Bln Deal - Quick Facts

Sanofi (SNYNF,SNY) said Monday that it agreed to acquire Principia Biopharma Inc. (PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, for $100 per share in cash, representing an aggregate equity value of about $3.68 billion.

The Boards of Directors of the companies approved the transaction.

Sanofi expects to commence a cash tender offer for Principia common stock later this month.

Sanofi plans to finance the transaction with cash on hand,and expects to complete the acquisition in the fourth quarter of 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health Corp. is hiring 15,000 employees across the U.S. in the fourth quarter to better equip them to tackle the anticipated rise in COVID-19 and flu incidences during the fall and winter months. This is in addition to the recruitment announced in March to fill 50,000 new full-time, part-time and temporary roles across the country in support of the company's response to the pandemic. Ireland's Data Protection Commissioner or DPC, the European Union's main data privacy regulator, is investigating Facebook over its handling of millions of children's personal data on Instagram, reports said. The agency has started two separate inquiries regarding information that email addresses and phone numbers of users under 18 were made public by the Facebook-owned app. ConocoPhillips (COP) and Concho Resources (CXO) announced Monday that they have entered into a definitive agreement to combine companies in an all-stock transaction valued at $9.7 billion. The transaction creates a company with an approximately $60 billion enterprise value and a combined resource...
Follow RTT